CALIXAR to extend its portfolio of strategic compounds for complex pharmaceutical target isolation

June 16, 2014

CALIXAR, company specialized in the native isolation of integral membrane protein targets, announced today the issue of a new generation of compounds able to extract and stabilize complex pharmaceutical targets.

Share this post

Secure and boost
your discovery programs

Starting from native material or recombinant systems, we succeed with all types of proteins: Kinases, Phosphatases, Ubiquitins, Epigenetic Proteins, GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.